Literature DB >> 9220938

Contemporary practice patterns in the management of newly diagnosed hypertension.

F A McAlister1, K K Teo, R Z Lewanczuk, G Wells, T J Montague.   

Abstract

OBJECTIVE: To determine what proportion of patients with hypertension are managed in accordance with guidelines established by the Canadian Hypertension Society.
DESIGN: Retrospective medical record review.
SETTING: Outpatients seen in primary care offices and internal medicine referral clinics in Edmonton. PATIENTS: All 969 adults who presented with a new diagnosis of essential hypertension from Sept. 1, 1993, to Dec. 31, 1995. OUTCOME MEASURES: Initial laboratory tests performed, advice concerning nonpharmacologic treatment given, antihypertensive drugs prescribed and any contraindications to thiazide diuretics or beta-adrenergic blocking agents documented.
RESULTS: The mean age of the 969 patients in the sample was 52.5 years; 129 (13%) of the patients were older than 70 years of age; and 500 (52%) were women. Most of the patients (704, 73%) had mild or moderate diastolic hypertension. In the 617 patients who underwent laboratory tests related to hypertension, the creatinine level was determined in 466 (76%), the cholesterol level in 372 (60%), a urinalysis was conducted in 378 (61%), the serum potassium level was checked in 343 (56%), the sodium level in 323 (52%) and an electrocardiogram was performed in 303 (49%). Liver function tests, which are not recommended in the guidelines, were performed in 338 patients (55%). Although there were differences in prescribing among physicians in the 711 patients given first-line therapy, most (238, 34%) were prescribed angiotensin-converting-enzyme (ACE) inhibitors. Lifestyle modification, without drug therapy, was suggested for 180 (25%) of the patients. Although the guidelines recommend their use for first-line drug therapy, only 82 patients (12%) were given beta-adrenergic blocking agents and only 75 (11%) were given thiazide diuretics. Of the patients who were prescribed an antihypertensive other than a thiazide or beta-adrenergic blocking agent as first-line drug therapy, only 161 (43%) had a documented contraindication to thiazides or beta-adrenergic blocking agents.
CONCLUSIONS: There is variation in the contemporary care of patients with hypertension. Further studies are required to determine the reasons underlying physicians' noncompliance with the evidence-based guidelines established by the Canadian Hypertension Society.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9220938      PMCID: PMC1227658     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  42 in total

1.  The concept of individualized hypertension care in general practice and outpatient clinics. The general practitioner hypertension practice study (III).

Authors:  M Ribacke
Journal:  Scand J Prim Health Care       Date:  1995-06       Impact factor: 2.581

2.  The Alberta Heart Health Survey: methods and results.

Authors:  M R Joffres; K L Titanich; P A Hessel
Journal:  Can J Cardiol       Date:  1993-05       Impact factor: 5.223

Review 3.  Report of the Canadian Hypertension Society Consensus Conference: 5. Hypertension and diabetes.

Authors:  K G Dawson; J K McKenzie; S A Ross; J L Chiasson; P Hamet
Journal:  CMAJ       Date:  1993-09-15       Impact factor: 8.262

Review 4.  Report of the Canadian Hypertension Society Consensus Conference: 1. Introduction.

Authors:  S G Carruthers; P Larochelle; R B Haynes; A Petrasovits; E L Schiffrin
Journal:  CMAJ       Date:  1993-08-01       Impact factor: 8.262

5.  Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations.

Authors:  J M Grimshaw; I T Russell
Journal:  Lancet       Date:  1993-11-27       Impact factor: 79.321

6.  Temporal patterns of antihypertensive medication use among elderly patients. The Cardiovascular Health Study.

Authors:  B M Psaty; P J Savage; G S Tell; J F Polak; C H Hirsch; J M Gardin; R H McDonald
Journal:  JAMA       Date:  1993-10-20       Impact factor: 56.272

Review 7.  Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of essential hypertension.

Authors:  R I Ogilvie; E D Burgess; J R Cusson; R D Feldman; L A Leiter; M G Myers
Journal:  CMAJ       Date:  1993-09-01       Impact factor: 8.262

8.  Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group.

Authors:  J D Neaton; R H Grimm; R J Prineas; J Stamler; G A Grandits; P J Elmer; J A Cutler; J M Flack; J A Schoenberger; R McDonald
Journal:  JAMA       Date:  1993-08-11       Impact factor: 56.272

Review 9.  Report of the Canadian Hypertension Society Consensus Conference: 2. Diagnosis of hypertension in adults.

Authors:  R B Haynes; Y Lacourcière; S W Rabkin; F H Leenen; A G Logan; N Wright; C E Evans
Journal:  CMAJ       Date:  1993-08-15       Impact factor: 8.262

Review 10.  Report of the Canadian Hypertension Society Consensus Conference: 4. Hypertension in the elderly.

Authors:  R A Reeves; J G Fodor; C I Gryfe; C Patterson; J D Spence
Journal:  CMAJ       Date:  1993-09-15       Impact factor: 8.262

View more
  19 in total

1.  New Canadian hypertension recommendations. So what?

Authors:  N R Campbell
Journal:  Can Fam Physician       Date:  2000-07       Impact factor: 3.275

Review 2.  Measuring adherence to practice guidelines for the management of hypertension: an evaluation of the literature.

Authors:  Jessica L Milchak; Barry L Carter; Paul A James; Gail Ardery
Journal:  Hypertension       Date:  2004-09-20       Impact factor: 10.190

3.  Implementation of recommendations on hypertension: the Canadian Hypertension Education Program.

Authors:  Denis Drouin; Norman R Campbell; Janusz Kaczorowski
Journal:  Can J Cardiol       Date:  2006-05-15       Impact factor: 5.223

4.  Development of explicit criteria to measure adherence to hypertension guidelines.

Authors:  J L Milchak; B L Carter; G Ardery; H R Black; G L Bakris; D W Jones; C D Kreiter
Journal:  J Hum Hypertens       Date:  2006-06       Impact factor: 3.012

5.  Randomized clinical trials of antihypertensive drugs: all that glitters is not gold.

Authors:  F A McAlister; S Straus; D Sackett
Journal:  CMAJ       Date:  1998-09-08       Impact factor: 8.262

6.  Influencing prescribing patterns.

Authors:  P Huston; N R Campbell
Journal:  Can Fam Physician       Date:  1998-02       Impact factor: 3.275

7.  Persistence with treatment for hypertension in actual practice.

Authors:  J J Caro; M Salas; J L Speckman; G Raggio; J D Jackson
Journal:  CMAJ       Date:  1999-01-12       Impact factor: 8.262

Review 8.  The management of hypertension in Canada: a review of current guidelines, their shortcomings and implications for the future.

Authors:  F A McAlister; N R Campbell; K Zarnke; M Levine; I D Graham
Journal:  CMAJ       Date:  2001-02-20       Impact factor: 8.262

9.  The impact of cardiovascular risk-factor profiles on blood pressure control rates in adults from Canada and the United States.

Authors:  Finlay A McAlister; Cynthia Robitaille; Cathleen Gillespie; Keming Yuan; Deepa P Rao; Steven Grover; Sulan Dai; Helen Johansen; Michel Joffres; Fleetwood Loustalot; Norm Campbell
Journal:  Can J Cardiol       Date:  2013-03-01       Impact factor: 5.223

10.  Laboratory testing in newly treated elderly hypertensive patients without co-morbidities: a population-based cohort study.

Authors:  Finlay Aleck McAlister; Karen Tu; Sumit R Majumdar; Rajdeep Padwal; Zhongliang Chen; Norman R C Campbell
Journal:  Open Med       Date:  2007-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.